ARCHIVES

The Selling Begins: CT Offered Beyond High-Risk Group

This article is from The Cancer Letter archive.

Vol. 36 No. 43 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

April 23, 2004

I-ELCAP: NEJM And Other Journals Seek Information On The Study’s Confidential Review From Henschke And Her Employers

May 6, 2011

Cancer Advocacy: Jay Hedlund Resigns As NPCC President

May 14, 1999

Nexavar Improves PFS In HER-2 Negative Breast Cancer

May 27, 2011

GSK’s Votrient Approved For Advanced Kidney Cancer

October 30, 2009

In Brief: Sartorelli Replaces Cole As Director Of Yale Comprehensive Center; NSABP Ends Segmental Trials

March 2, 1984